Please provide your email address to receive an email when new articles are posted on . Pulmonary hypertension appears in 25% to 30% of patients with COPD. There are no approved therapies for patients ...

Jeffrey D. Dunn, PharmD, MBA, leads a panel discussion on disease and treatment landscapes for COPD. Jeffrey D. Dunn, PharmD, MBA: Hello, and welcome to this AJMC® program titled “Medication ...

Asthma and COPD share similar breathing symptoms, often leading to confusion and misdiagnosis. Know key differences, risks of ...

Chronic lower respiratory diseases, namely, asthma and chronic obstructive pulmonary disease (COPD), are the fifth-leading cause of death in the United States. A contributing factor is diagnostic ...

US patients with chronic obstructive pulmonary disease (COPD) managed in primary care settings have high exacerbations, symptoms, and treatment burdens, according to an analysis of electronic health ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. When a patient made a ...

New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are ...

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)-- Patients with chronic obstructive pulmonary disease (COPD) face significant challenges, but conversations with healthcare providers can play a ...

Gabapentinoid use in patients with chronic obstructive pulmonary disease (COPD) was associated with a higher risk for severe exacerbations, a population-based cohort study from Canada indicated. Among ...

During the Chicago Marathon, thousands of runners were short of breath at the end of the grueling race. But one runner took on 26.2 with just 30 percent lung capacity. Eleven years ago, Russell ...